Global markets rise after US-EU trade agreement
The US struck a framework trade agreement with the European Union, imposing a 15 per cent import tariff on most EU goods – half the threatened rate, a week after agreeing to a trade deal with Japan that lowered proposed tariffs on auto imports.
Countries are scrambling to finalise trade deals ahead of an August 1st deadline set by US president Donald Trump, with talks between the US and China set for Monday in Stockholm amid expectations of another 90-day extension to the truce between the world's top two economies.
'A 15 per cent tariff on European goods, forced purchases of US energy and military equipment and zero tariff retaliation by Europe, that's not negotiation, that's the art of the deal,' said Prashant Newnaha, senior Asia-Pacific rates strategist at TD Securities. 'A big win for the US.'
READ MORE
S&P 500 futures rose 0.4 per cent and the Nasdaq futures gained 0.5 per cent while the euro firmed across the board, rising against the dollar, sterling and yen. European futures surged nearly 1 per cent.
MSCI's broadest index of Asia-Pacific shares outside Japan was up 0.27 per cent, just shy of the almost four-year high it touched last week. Japan's Nikkei fell 0.8 per cent after hitting a one-year high last week.
While the baseline 15 per cent tariff will still be seen by many in Europe as too high, compared with Europe's initial hopes to secure a zero-for-zero tariff deal, it is better than the threatened 30 per cent rate.
The US-EU deal provides clarity to companies and averts a bigger trade war between the two allies that account for almost a third of global trade.
'A major tail-risk has now been defused,' said Marc Velan, head of investments at Lucerne Asset Management in Singapore.
'Markets are interpreting this as a sign of stability and predictability returning to trade policy,' he added. 'The China delay fits the same pattern: the administration is opting for controlled diplomacy over confrontation.'
China's blue-chip stocks rose 0.3 per cent while the Hong Kong's Hang Seng index advanced 0.75 per cent.
The Australian dollar, often seen as a proxy for risk appetite, was at $0.657, hovering around the near eight-month peak scaled last week.
In an action-packed week, investors will watch out for the monetary policy meetings from the Fed and the BOJ as well as the monthly US employment report and earnings from megacap companies Apple, Microsoft and Amazon.
While the Fed and the BOJ are expected to maintain rates, comments from the officials will be crucial for investors to gauge the interest rate path. The trade deal with Japan has opened the door for the BOJ to raise rates again this year.
Meanwhile, the Fed is likely to be cautious on any rate cuts as officials seek more data to determine tariffs' impact on inflation before they ease rates further.
But tensions between the White House and the central bank over monetary policy have increased, with Trump repeatedly lashing out at Fed chair Jerome Powell for not cutting rates. Two of the Fed Board's Trump appointees have articulated reasons for supporting a rate cut this month.
'Inflation readings, particularly the PCE index, and the upcoming July jobs report will shape expectations beyond this meeting, with the next likely policy pivot now pushed out to September if inflation continues to ease,' said Kieran Williams, head of Asia FX at InTouch Capital Markets.
In commodities, oil prices rose after the US-EU trade agreement. Brent crude futures and US West Texas Intermediate crude both rose 0.5 per cent.
Gold prices fell on Monday to their lowest in nearly two weeks on reduced appetite for safe havens. – Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
an hour ago
- Irish Times
Trump hails additional $100bn Apple investment in US
US President Donald Trump will announce an additional $100 million investment by tech giant Apple in its US manufacturing network, White House officials said on Wednesday. It comes as Apple tries to avoid US tariffs on imports that will impact the cost of iPhones and other products in the US. The announcement will be seen by the Trump administration as a big victory is his crusade to restore domestic manufacturing. But the scale of the investment will raise concerns in Irish Government circles about what it might mean for the company's commitment to its Irish manufacturing base, which employs more than 6,000 staff. The US president is hoping his threat of tariffs on imports will pressure companies to increase manufacturing inside the US, the stated aim of his America First agenda. READ MORE 'President Trump's America First economic agenda has secured trillions of dollars in investments that support American jobs and bolster American businesses,' White House spokeswoman Taylor Rogers said in a statement. 'Today's announcement with Apple is another win for our manufacturing industry that will simultaneously help reshore the production of critical components to protect America's economic and national security,' he said. In February, Apple said it planned to hire an additional 20,000 staff in the US over the next four years, as part of a $500 billion investment in the country during Trump's second term in office, a figure that is now expected to increase to $600 billion. The company made similar, smaller pledges during the Biden administration and Trump's first term, though it has not yet followed through on some of those promises. While Apple supports more than 450,000 jobs with thousands of suppliers and partners across 50 states, the president has been concerned at the company's plan to expand its manufacturing footprint in India. In May, Trump threatened Apple and other phone manufacturers with a 25% tariff on products made outside the United States. Bloomberg Intelligence analysts Anurag Rana and Andrew Girard said the latest Apple pledge of investment may 'soften the White House's ire' over Apple's heavy reliance on India for iPhone assembly. 'We anticipate Apple will focus on higher-end products, artificial intelligence labs and semiconductor engineering in the US, rather than mass-produced lower-end phones and accessories.' Mr Trump's announcement, which was reported earlier by Bloomberg, will include the creation of what the White House is calling the 'American Manufacturing Programme', which will focus on bringing more of Apple's supply chain and advanced manufacturing to the United States. The US president is hoping his threat of tariffs on imports will pressure companies to increase manufacturing inside the US, the stated aim of his America First agenda. The Apple announcement comes on the day that Mr Trump signed an executive order imposing an additional 25 per cent tariff on imports from India which, he said, was due to New Delhi's purchases of Russian oil. The order said the 25 per cent levies would be added to existing duties imposed on Indian imports in a move that will raise tensions with prime minister Narendra Modi's government. India has failed to reach a trade deal with Washington and was already facing 25 per cent tariffs on its exports to the US before Mr Trump's announcement. A 15 per cent tariff on most EU exports to the US is scheduled to come into force on Thursday. Both the European Commission and the While House had confirmed previously that the 15 per cent rate would include pharmaceuticals and semiconductors. However, comments by the US president on Tuesday when he warned of tariffs on pharmaceuticals of up to 250 per cent over coming years, naming Ireland as a target alongside China, will cause concern in Dublin. – Additional reporting Bloomberg, New York Times, Financial Times limited
RTÉ News
3 hours ago
- RTÉ News
Tax take to end of July up 7.5% on same time last year
The amount of tax collected by the State between January and the end of July was up by 7.5% on the same time last year, when once off payments related to the Apple tax ruling are excluded. The latest Exchequer Returns show that so far this year, €56.2bn in tax receipts were collected, an increase of €3.9bn on the first seven months of 2024. All the major tax categories recorded growth last month, reflecting strong economic growth despite the concerns over the impact of tariffs. When the once-off tax receipts arising from the Court of Justice of the European Union on the Apple tax are excluded, the tax revenue so far this year stands at €58bn, which is €5.6bn or 10.8% higher than the end of July 2024. €20.3bn of the total came from income tax, which was 3.9% higher than what was collected in the first seven months of last year. July is not a key month for corporation tax, but excluding the Apple payment, corporation tax take for the year to date is well ahead of last year, up by 14.1% to €14.3bn. The figure represents an increase of €1.8bn on the number at the end of July 2024. July is an important month for VAT returns. The latest Exchequer Returns show receipts of €3.3bn were collected last month, €46m or 1.4% ahead of the same month last year. It takes the total VAT revenue for the year so far to €14.8bn, which is €0.7bn or 4.8% up on 2024. Total gross voted expenditure to the end-July amounted to €60.5bn, which is €4.8bn or 8.6% ahead of the same period last year. The spending is €0.3bn or 0.6% ahead of projections.
Irish Times
6 hours ago
- Irish Times
Tariffs: what do Trump's latest pharma threats mean for Ireland?
How likely was it that Donald Trump would seek to change the goalposts of his trade deal with the EU? Most people would have said, very. Despite assertions from the European Commission that the deal would bring clarity and certainty to exporters, confusion reigns. Less than 24 hours before the new 15 per cent tariff regime comes into force, Trump is already talking about imposing tariffs of up to 250 per cent on pharma exports from Europe, just days after we were told any pharma tariffs would be capped at 15 per cent. 'We'll be putting a initially small tariff on pharmaceuticals, but in one year – one and a half years, maximum – it's going to go to 150 per cent and then it's going to go to 250 per cent because we want pharmaceuticals made in our country,' Trump said on Tuesday. 'They [pharmaceutical companies] make a fortune with pharmaceuticals, and they make in China and Ireland and everything else,' he said. READ MORE What does this mean for Ireland? If Trump is to be taken at his word, and that's a big if, this could be spell big trouble for Ireland. Most of the State's €70 billion plus exports to the US comprise pharma-related products. Ireland plays host to most of the big names in the global pharma trade. Pfizer, Merck, Eli Lilly, to name but a few, use Ireland as a base from which to export globally. A 15 per cent tariff on their exports to the US – the rate we were told we were getting – would have been detrimental but perhaps manageable; a rate of 150 or 250 per cent would kill off the trade altogether, placing question marks over the Irish operations of these firms and Ireland's ability to attract future foreign investment. Said another way, the State's economic model would be under threat. But will Trump make good on his threat? Again, there's no way of knowing but relying on the so-called Taco (Trump always chickens out) dynamic is not realistic. Trump has singled out pharma as one of the main drivers of the US's big trade deficit (in goods) with the EU and, going back even to his first term, has frequently lashed out at the industry for presiding over high drug prices in the US. His crusade could, however, run into a few roadblocks. For one, drug demand is relatively inelastic. People can't exactly jump off their prescription medications because they don't like the price. One of main drivers of high prices in the US is also the country's complex healthcare system, which includes a large private insurance industry with multiple intermediaries. And, of course, multinationals cannot just switch their 10-year investment cycles overnight. The nightmare scenario for Ireland? The nightmare scenario for Ireland would be for a Pfizer to up sticks and leave in the face of Trump's protectionist agenda. There's no way of telling how current US policies are influencing decision-making in the boardrooms of these companies. Like everyone else, they are probably adopting a wait-and-see approach. But there's likely to be a lot of push back against Trump's tariff threats. These companies are very profitable, particularly for their Wall Street investors and Trump's policies fly in the face of that. What about the non-pharma trade? As per the agreement last week, a baseline tariff of 15 per cent will apply to most, not all, EU exports into the US from Thursday. That's better than the 30 per cent initially threatened by Trump and the 39 per cent that the White House suddenly imposed on Switzerland last week. Many Irish food and drink exporters operate in price-sensitive sectors and the recalibration could be difficult. Some Irish whiskey exporters may be forced 'to reorientate their focus away' from the US if a 15 per cent tariff rate applies, the Irish Whiskey Association warned last week. As the US is their biggest market, that is easier said than done. What else? Of course, the big question surrounding Trump's protectionist trade agenda is how will it impact the US economy. A big slide in performance there – and there are preliminary signs of this in the latest jobs data – and Trump may have to soften his stance. He is already hounding Federal Reserve boss, Jerome Powell, to reduce interest rates to cushion any impact of tariffs but with inflation ticking up, that's unlikely. It's a bit of a double-edged sword for Ireland, the State naturally doesn't want tariffs but, equally, it doesn't want a US recession either.
